Cytokinetics (NASDAQ:CYTK) Upgraded by Morgan Stanley to Overweight Rating
Morgan Stanley upgraded shares of Cytokinetics (NASDAQ:CYTK – Free Report) from an equal weight rating to an overweight rating in a research note issued to investors on Thursday morning,Benzinga reports. They currently have $67.00 price objective on the biopharmaceutical company’s stock, down from their prior price objective of $70.00. CYTK has been the subject of […]
More Stories
Announcement! 1670 Season 4 is Releasing Soon! Release Date, Trailer Updates, and More
Hello! Polish TV series and movie fans. 1670 is going to end soon. With great reviews and huge viewership, the...
Semrush vs Serpstat vs Ahrefs: Which Is Better?
No business today can skip search engine optimization if they want to lead in the online marketplace. From keyword research...
Murder in a Small Town Season 3 Is Releasing Soon on Netflix
Murder in a Small Town Season 3 is coming back with an-all-new drama and suspenseful storyline for its viewers. The...
Netflix’s Fauda Season 5: Release Date, Cast Members, Plot, and Episodes
Fauda season 5 is coming to Netflix soon! Your years of waiting are finally over. Are you also one of...
How to Cancel Hulu Subscriptions? A Complete Guide For Beginners
Worried about your money being deducted? Do you also have a subscription and now don’t know how to cancel your...
Dolly Parton, queen of country music, dies at 80
By Reuters Aug 25 (Reuters) – Dolly Parton was around six when she wrote her first song: “Little Tiny Tasseltop,”...